Sex differences in Parkinson disease-associated episodic memory and processing speed deficits
Tyler H Reekes1,2, Christopher I Higginson3, Karen A Sigvardt4
1Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Summary
Males with Parkinson disease (PD) show worse cognitive function than females, particularly in memory and processing speed. This suggests males may have a specific PD subgroup susceptible to frontal lobe decline.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Cognitive dysfunction is a common non-motor symptom in Parkinson disease (PD).
- Existing data suggests cognitive impairment may be more severe in males with PD, but specific cognitive domains require further investigation.
Purpose of the Study:
- To investigate sex-specific differences in cognitive function, specifically episodic memory and processing speed, in individuals with Parkinson disease.
- To address the incomplete data regarding cognitive sex differences in Parkinson disease.
Main Methods:
- 167 individuals diagnosed with PD (56 female) were assessed.
- Episodic memory evaluated using California Verbal Learning Test and Wechsler Memory Scale.
- Processing speed assessed using Wechsler Adult Intelligence Scale.
- Multivariate analysis of covariance used to analyze sex-specific differences.
Main Results:
- Males with PD performed significantly worse than females in verbal and visuospatial recall.
- A trend for poorer performance in males with PD was observed in the processing speed task (coding).
Conclusions:
- Females with PD demonstrated superior verbal episodic memory compared to males, consistent with prior research.
- Females with PD also outperformed males in visuospatial episodic memory, a novel finding unique to this disease.
- Cognitive deficits in males with PD may be linked to frontal lobe dysfunction, suggesting a potential disease subgroup susceptible to frontal lobe deterioration.
Related Concept Videos
Parkinson's Disease: Treatment
321
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
321
Parkinson's Disease: Overview
633
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
633
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K


